{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:05:26Z","timestamp":1778987126809,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The 2013 HIV Organ Policy Equity Act has increased liver transplantation (LT) in HIV<jats:sup>+<\/jats:sup> patients; however, transplant centers may remain reluctant to perform LT in HIV\/hepatitis C virus (HCV)-coinfected patients due to inferior outcomes. We aimed to assess how direct-acting antivirals (DAAs) have impacted HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup>-coinfected LT recipient outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>national data including 70\u2009125 adult LT recipients between 2008 and 2019 were analyzed. Kaplan-Meier survival analysis and Cox proportional hazards model were used to analyze outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>LT for HIV<jats:sup>+<\/jats:sup> individuals increased in the DAA era from 28 in 2014 to 64 in 2019 (23 had HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup> coinfection). In the pre-DAA era, HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup>-coinfected LT recipients had an increased risk of graft failure compared with HIV<jats:sup>\u2212<\/jats:sup>\/HCV<jats:sup>\u2212<\/jats:sup>-uninfected LT recipients (hazard ratio [HR], 1.85; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). In contrast, there was no difference in graft failure between HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup>-coinfected versus HIV<jats:sup>\u2212<\/jats:sup>\/HCV<jats:sup>\u2212<\/jats:sup>-uninfected LT recipients in the DAA era (HR, 1.24; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.308). Among coinfected LT recipients in the DAA era, 1- and 3-y cumulative graft survivals were 88.6% and 81.7% compared with 76.3% and 58.0% in the pre-DAA era, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.006). In Cox analysis, HCV coinfection was not associated with graft failure (HR, 1.00; 95% confidence interval, 0.53-1.89) among HIV<jats:sup>+<\/jats:sup> LT recipients in the DAA era (n\u2009=\u2009271). Black and Hispanic populations accounted for almost half of HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup> LTs in the DAA era.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>HIV<jats:sup>+<\/jats:sup>\/HCV<jats:sup>+<\/jats:sup>-coinfected LT recipient outcomes have improved significantly in the DAA era. Our results should offer reassurance to transplant centers and encourage timely transplantation referral of HIV patients with decompensated cirrhosis, including patients coinfected with HCV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001154","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T18:00:41Z","timestamp":1623261641000},"page":"e707","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["\u201cRaising HOPE\u201d: Improved Outcomes for HIV\/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era"],"prefix":"10.1097","volume":"7","author":[{"given":"Thomas G.","family":"Cotter","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Lieber","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Odenwald","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole E.","family":"Rich","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Marrero","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mack C.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Aronsohn","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Charlton","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fung","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2893.2007.00903.x","article-title":"Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.","volume":"15","author":"Castellares","year":"2008","journal-title":"J Viral Hepat"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/lt.20261","article-title":"Liver transplantation in patients with HIV infection.","volume":"10","author":"Fung","year":"2004","journal-title":"Liver Transpl"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1111\/ajt.15494","article-title":"National landscape of HIV+ to HIV+ kidney and liver transplantation in the United States.","volume":"19","author":"Wilk","year":"2019","journal-title":"Am J Transplant"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.","volume":"6","author":"de Vera","year":"2006","journal-title":"Am J Transplant"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","article-title":"HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.","volume":"41","author":"Pineda","year":"2005","journal-title":"Hepatology"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2014.10.032","article-title":"Outcome and management of HCV\/HIV coinfection pre- and post-liver transplantation. A 2015 update.","volume":"62","author":"Miro","year":"2015","journal-title":"J Hepatol"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/cid\/civ471","article-title":"Beyond the NIH multicenter HIV transplant trial experience: outcomes of HIV+ liver transplant recipients compared to HCV+ or HIV+\/HCV+ coinfected recipients in the United States.","volume":"61","author":"Sawinski","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","article-title":"Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.","volume":"12","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.","volume":"47","author":"Duclos-Vall\u00e9e","year":"2007","journal-title":"Hepatology"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.24062","article-title":"Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection.","volume":"53","author":"Vibert","year":"2011","journal-title":"Hepatology"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/ciw219","article-title":"Management of hepatitis C\/HIV coinfection in the era of highly effective hepatitis C virus direct-acting antiviral therapy.","volume":"63","author":"Wyles","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.2015.1328","article-title":"Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.","volume":"313","author":"Sulkowski","year":"2015","journal-title":"JAMA"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.25424","article-title":"Improved graft survival after liver transplantation for recipients with hepatitis C virus in the direct-acting antiviral era.","volume":"25","author":"Cotter","year":"2019","journal-title":"Liver Transpl"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hep.30540","article-title":"Increasing utilization and excellent initial outcomes following liver transplant of hepatitis C virus (HCV)-viremic donors into HCV-negative recipients: outcomes following liver transplant of HCV-viremic donors.","volume":"69","author":"Cotter","year":"2019","journal-title":"Hepatology"},{"key":"R20-20240805","article-title":"Liver transplantation of HCV-viremic donors into HCV-negative recipients in the USA: increasing frequency with profound geographic variation.","author":"Cotter","year":"2020","journal-title":"Transplantation"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/TP.0000000000003107","article-title":"Temporal trends and outcomes in liver transplantation for recipients with HIV infection in Europe and United States.","volume":"104","author":"Campos-Varela","year":"2020","journal-title":"Transplantation"},{"key":"R23-20240805","article-title":"Organ for Procurement and Transplantation Network: Scientific Registry of Transplant Recipients.","journal-title":"The SRTR Database: Overview"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"e0134874","DOI":"10.1371\/journal.pone.0134874","article-title":"Factors associated with mortality and graft failure in liver transplants: a hierarchical approach.","volume":"10","author":"Haddad","year":"2015","journal-title":"PLoS One"},{"issue":"No. 1","key":"R26-20240805","article-title":"Estimated HIV incidence and prevalence in the United States, 2014\u20132018.","volume":"25","year":"2020","journal-title":"HIV Surveillance Supplemental Report"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1600-6143.2005.00812.x","article-title":"Determinants of transplant surgeons\u2019 willingness to provide organs to patients infected with HBV, HCV or HIV.","volume":"5","author":"Halpern","year":"2005","journal-title":"Am J Transplant"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/ajt.14993","article-title":"Organs from deceased donors with false-positive HIV screening tests: an unexpected benefit of the HOPE act.","volume":"18","author":"Durand","year":"2018","journal-title":"Am J Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:08:43Z","timestamp":1722834523000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001154","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}